In 2023, Strides Pharma Science completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Strides Pharma Science has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2023, the total operational greenhouse gas (GHG) emissions of Strides Pharma Science amounted to 25,553 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Strides Pharma Science decreased by 2.34%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
In 2023, the total Scope 1 emissions of Strides Pharma Science were 6,168 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Compared to the previous year (2022), Strides Pharma Science's Scope 1 emissions remained relatively stable, indicating that Strides Pharma Science's emissions have plateaued with no significant change in its operational footprint.
In 2023, Strides Pharma Science reported Scope 2 greenhouse gas (GHG) emissions of 19,385 tCOâ‚‚e without specifying the calculation method.
Compared to the previous year (2022), Strides Pharma Science's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Strides Pharma Science 's emissions have plateaued with no significant change in its energy consumption footprint.
In 2023, Strides Pharma Science reported its Scope 2 emissions using an unspecified methodology.